Tonix Pharmaceuticals (TNXP) stock gains as the company posts peer-reviewed data for pain drug TNX-102 and new data for mpox ...

Tonix Pharmaceuticals Holding Corp TNXP Company Vitals Ranked in Earnings Gainer Data delayed 15 minutes Overview Interactive Chart Company Vitals ...

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) saw its stock rise 2% after unveiling new preclinical findings for its ...

Tonix and Tunes Bar and Lounge is opening in Topeka's NOTO Arts and Entertainment District. Topeka's nightlife will soon ...

Single dose vaccination with TNX-801 protects animals from a lethal challenge with monkeypox, the causative agent of mpox TNX ...

Tonix Pharmaceuticals (NASDAQ:TNXP) intends to offer and sell shares of its common stock. All of the securities to be sold in the offering are to be offered by Tonix. Source: Press Release More on ...

Tonix Pharmaceuticals Holding Corp.* Tonix is a fully-integrated biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and ...

--Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, today announced financial results for the fourth quarter and full year ended December 31, 2022, and provided an ...

Tonix Pharmaceuticals Holding Corp. * Tonix is a fully-integrated biopharmaceutical company focused on transforming therapies for pain management and vaccines for public health challenges.

Tonix Pharmaceuticals has entered into an agreement to acquire two fast-acting migraine treatments from Upsher-Smith Laboratories LLC.

Tonix Pharmaceuticals' new drug shows promise in relieving fibromyalgia pain without addiction risk, according to Phase 3 trial results.

CHATHAM, N.J., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of ...